Wed, June 1, 2022

Emmanuel Papadakis Maintained (BNTX) at Hold and Held Target at $180 on, Jun 1st, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-180-on-jun-1st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Emmanuel Papadakis of Deutsche Bank, Maintained "BioNTech SE" (BNTX) at Hold and Held Target at $180 on, Jun 1st, 2022.

Emmanuel has made no other calls on BNTX in the last 4 months.



There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 3 agree with Emmanuel's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $206 on, Tuesday, May 24th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $195 on, Tuesday, May 10th, 2022
  • Simon Baker of "Redburn Partners" Upgraded from Strong Sell to Hold on, Tuesday, February 1st, 2022


These are the ratings of the 2 analyists that currently disagree with Emmanuel


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $298 on, Tuesday, April 12th, 2022
  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $300 on, Tuesday, April 5th, 2022